Education
About Us
Working with TipRanks
Follow Us
PEPTONIC medical AB (DE:28L)
FRANKFURT:28L
28L Stock Chart & Stats
Day’s RangeN/A
52-Week Range― - ―
Previous CloseN/A
Volume0.00
Average Volume (3M)N/A
Market Cap
€1.50M
Enterprise Value€1.66M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.11
Next Earnings
Nov 06, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding9,337,409,000
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
28L FAQ
What was PEPTONIC medical AB’s price range in the past 12 months?
Currently, no data Available
What is PEPTONIC medical AB’s market cap?
PEPTONIC medical AB’s market cap is €1.50M.
When is PEPTONIC medical AB’s upcoming earnings report date?
PEPTONIC medical AB’s upcoming earnings report date is Nov 06, 2025 which is in 43 days.
How were PEPTONIC medical AB’s earnings last quarter?
PEPTONIC medical AB released its earnings results on Aug 13, 2025. The company reported €0 earnings per share for the quarter, the consensus estimate of N/A by €0.
Is PEPTONIC medical AB overvalued?
According to Wall Street analysts PEPTONIC medical AB’s price is currently Overvalued.
Does PEPTONIC medical AB pay dividends?
PEPTONIC medical AB does not currently pay dividends.
What is PEPTONIC medical AB’s EPS estimate?
PEPTONIC medical AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PEPTONIC medical AB have?
PEPTONIC medical AB has 9,337,409,000 shares outstanding.
What happened to PEPTONIC medical AB’s price movement after its last earnings report?
PEPTONIC medical AB reported an EPS of €0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of PEPTONIC medical AB?
Currently, no hedge funds are holding shares in DE:28L
Company Description
PEPTONIC medical AB
PEPTONIC medical AB is a pharmaceutical company. It is engaged in developing oxytocin-based products for the treatment of menopausal symptoms, such as vaginal atrophy and vaginal dryness. Oxytocin is for medical use and offers an alternative to estrogen and estrogen-like acting compounds for menopausal and postmenopausal women. The company is based in Sweden.